HEALTH

Study: Many don’t inform doctors of smoking habit

BY Michael Johnsen

WASHINGTON — Approximately 13% of smokers do not disclose their tobacco habit to their healthcare provider, according to a recent survey released by the American Legacy Foundation. And while a majority of smokers did admit their smoking status, only some 25% sought help from their doctors or healthcare providers during their last attempt to quit. 


“Healthcare providers play a critical role in reaching smokers with appropriate messages and resources for quitting, especially now that insurance coverage has expanded to include some smoking cessation treatments,” stated Cheryl Healton, Legacy president and CEO. “It becomes a missed public health opportunity if what amounts to more than 6 million smokers in the United States do not talk to doctors and nurses about smoking and quitting.”


To address the void between doctors and all smokers, Legacy has developed a guide for healthcare providers with strategies on how to conduct more meaningful and effective conversations with their patients about smoking and quitting. 


Legacy is the national, independent public health foundation that was created in 1999 out of the landmark Master Settlement Agreement between the tobacco industry, 46 state governments and five U.S. territories.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Awareness expected 
to benefit diabetes, DME

BY Michael Johnsen

According to the American Diabetes Association’s latest figures, 79 million Americans have prediabetes, but only 1-out-of-10 knows it. That suggests a terrific upside in the market of diabetes-testing supplies and diabetes-supportive products as more of those Americans become aware of their condition. 


The opportunity, though, is in helping to manage the condition. An expected growth in medication therapy management offerings necessary to improve patient compliance and drive down healthcare costs, coupled with the continued advancement in telemedicine infrastructure — the iPodding of diabetes testing supplies — represent the real growth drivers beyond the simple projected increase in need for diabetes-related supplies.


There is a similar growth trajectory associated with the sale of durable medical equipment. Baby boomers, the first of whom celebrated their 65th birthdays last year, are still some 10 to 15 years from needing daily living assistance products themselves. But much of that business is migrating to the drug channel with consumers paying for those items with cash, as opposed to through insurers like Medicare because of a trend toward home health care versus nursing homes and a growing awareness that affordable DME products are available at retail.

 

 

The article above is part of the DSN Category Review Series. For the complete DME/Diabetes Buy-In Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Issues Summit panels attract record attendance

BY Antoinette Alexander

Record-breaking attendance and four panel discussions on such topics as specialty pharmacy and diabetes set the stage for the 13th annual Drug Store News Industry Issues Summit held on Nov. 29 in New York City. This year’s event attracted more than 30 retailers and 200 industry suppliers. 


Industry Issues Summit began 13 years ago as a small, closed-door event and has evolved into a must-attend day of education, networking and dialogue, with four separate panel discussions: Health, Wellness and Technology; Diabetes Leadership Forum; Specialty Pharmacy Leadership Summit; and Industry Issues Summit.


Retailer and supplier panelists discussed an array of issues impacting pharmacy. Topics ranged from the role specialty pharmacy can play in the management of new genetic and diagnostic testing, to the real value proposition of biosimilars, to the 2012 drivers that will impact specialty pharmacy.


Bob Dufour of Blue Ocean Innovative Solutions moderated the Health, Wellness and Technology panel; Dave Wendland of Hamacher Resource Group moderated the Diabetes Leadership Forum; and Dave Fong of Dave Fong Rx Consulting moderated the Specialty Pharmacy Leadership Summit. Participants for the three panels included: 


  • Will Abbott, director of pharmacy strategy and innovation at CVS;


  • Michael Agostino, president of Amber Pharmacy;


  • Mike Cantrell, president of Good Neighbor Pharmacy;


  • Anthony Davino, VP manufacturer relations at Armada Health Care;


  • Bart Foster, CEO and founder of SoloHealth;


  • Phil Hagerman, co-founder of Diplomat Specialty Pharmacy;


  • Aaron Kaufman, GM/VP healthcare/life sciences solutions at Kony Solutions;


  • Massoud Kazemzadeh, COO at Kay’s Naturals;


  • Debbie Krasnow, director of managed care at Giant Eagle;


  • Michael LaMotta, senior manager of trade operations at Novo Nordisk;


  • Ashton Maaraba, GM and COO of PharmaSmart International;


  • Lee Merritt, VP business development at Medfusion/Ascend Rx;


  • John Musil, founder and CEO of Apothecary Shops;


  • Leon Nevers, business development and professional services at H-E-B;


  • Craig Norman, SVP pharmacy at H-E-B;


  • Darren O’Neill, senior director of sponsored clinical services at Health Mart;


  • Dev Patel, SVP technology at Moonshado;


  • Rick Sage, VP pharmacy solutions at Emdeon;


  • Murali Sastry, director of payer contracting at BioPlus Specialty Pharmacy;


  • Erick Von Schweber, CEO and executive co-chair at Surveyor Health;


  • Effie Steele, clinical services coordinator at Meijer;


  • Ray Tancredi, senior director of trade account management/contracting operations at Walgreens;


  • James Weeast, senior director of Rx health and wellness technology at Walgreens;


  • Chuck Wilson, VP of Health Mart operations at McKesson;


  • Michael Wolf, director of diabetes care merchandising at Walgreens;


  • Alan Yates, VP product development at Numera Social; and


  • Brahim Zabeli, SVP sales and marketing at UltiMed;


  • Ceci Zeigler, national director of patient care services at Amerisource­Bergen/Good Neighbor Pharmacy; and


  • Burt Zweigenhaft, CEO of OncoMed.


The transcript of the Diabetes Summit will appear in the Feb. 27 issue of DSN; the full transcript of the technology summit will be available on Feb. 6 on DrugStoreNews.com; and the Specialty Pharmacy transcript will run in the spring edition of Specialty Pharmacy magazine.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?